List of works - Howard S

A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility ⬇️

scientific article published on May 4, 2011

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.

scientific article published on 26 August 2010

Adverse reactions to voriconazole.

scientific article

An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance.

scientific article published on 4 February 2014

Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.

scientific article published on 28 November 2011

Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

scientific article

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

scientific article published on 20 August 2010

Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.

scientific article published on 7 August 2009

Cryptic species and azole resistance in the Aspergillus niger complex.

scientific article

Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

scientific article

Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.

scientific article

Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.

scientific article published on 23 April 2012

EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.

scientific article

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

scientific article published on 28 January 2014

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

scientific article published on 21 July 2008

Flucytosine therapeutic monitoring: 15 years experience from the UK

scientific article published on 05 March 2007

Fungal contamination of bedding.

scientific article

Getting messier with TIDieR: embracing context and complexity in intervention reporting.

scientific article published on 18 January 2018

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

scientific article published on 03 September 2013

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

scientific article published on 16 September 2013

In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles

article

Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter

scientific article published on 29 August 2011

Major variations inAspergillus fumigatusarising within aspergillomas in chronic pulmonary aspergillosis

scientific article published on 01 February 2013

Mechanisms of Antifungal Drug Resistance

scientific article

Multi-azole resistance in Aspergillus fumigatus

scientific article published on 10 October 2006

Multi-resistant aspergillosis due to cryptic species.

scientific article published on 27 June 2014

Phaeohyphomycosis caused by Exophiala salmonis

scientific article published on 01 November 2006

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

scientific article

Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.

scientific article

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

scientific article published on 18 April 2013

Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.

scientific article

Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

scientific article published on 31 October 2012

Posaconazole: the case for therapeutic drug monitoring.

scientific article published on February 2012

Post-discharge care following acute kidney injury: quality improvement in primary care

scientific article published on 01 December 2020

Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis.

scientific article published on 20 January 2015

Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devriesii in a United Kingdom resident.

scientific article published in September 2006

Understanding the implementation of 'sick day guidance' to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation.

scientific article published on 8 November 2017

List of works by Howard S

A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility ⬇️

Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.

Adverse reactions to voriconazole.

An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance.

Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.

Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.

Cryptic species and azole resistance in the Aspergillus niger complex.

Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.

Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients.

EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

Flucytosine therapeutic monitoring: 15 years experience from the UK

Fungal contamination of bedding.

Getting messier with TIDieR: embracing context and complexity in intervention reporting.

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles

Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter

Major variations inAspergillus fumigatusarising within aspergillomas in chronic pulmonary aspergillosis

Mechanisms of Antifungal Drug Resistance

Multi-azole resistance in Aspergillus fumigatus

Multi-resistant aspergillosis due to cryptic species.

Phaeohyphomycosis caused by Exophiala salmonis

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.

Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

Posaconazole: the case for therapeutic drug monitoring.

Post-discharge care following acute kidney injury: quality improvement in primary care

Rate of cyp51A mutation in Aspergillus fumigatus among lung transplant recipients with targeted prophylaxis.

Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devriesii in a United Kingdom resident.

Understanding the implementation of 'sick day guidance' to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation.